Teresa Filshtein-Somnez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Teresa Filshtein-Somnez has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Adam Auton
23andMe Research Institute, Palo Alto, USA
1 shared publication - Anjali J. Shastri
23andMe Inc., 223 N Mathilda Ave, Sunnyvale, CA 94086
1 shared publication - Antony Symons
23andMe Inc., 223 N Mathilda Ave, Sunnyvale, CA 94086
1 shared publication - Catherine H. Weldon
23andMe Inc., 223 N Mathilda Ave, Sunnyvale, CA 94086
1 shared publication - Chelsea Ye
23andMe Inc., 223 N Mathilda Ave, Sunnyvale, CA 94086
1 shared publication - Daniella Coker
23andMe, Inc
1 shared publication
Latest Publications
- Open Access
Trans-ethnic analysis reveals genetic and non-genetic associations with COVID-19 susceptibility and severity
COVID-19 presents with a wide range of severity, from asymptomatic in some individuals to fatal in others. Based on a study of over one million 23andMe research participants, we report genetic and non-genetic associations with testing positive for COVID-19, respiratory symptoms, and hospitalization. Risk factors for hospitalization include advancing age, male sex, elevated body mass index, lower socio-economic status, non-European ancestry, and pre-existing cardio-metabolic and respiratory conditions. Using trans-ethnic genome-wide association studies, we identify a strong association between blood type and COVID-19 diagnosis, as well as a gene-rich locus on chr3p21.31 that is more strongly associated with outcome severity. While non-European ancestry was found to be a significant risk factor for hospitalization after adjusting for socio-demographics and pre-existing health conditions, we did not find evidence that these two primary genetic associations explain differences between populations in terms of risk for severe COVID-19 outcomes.
Open AccessTrans-ethnic analysis reveals genetic and non-genetic associations with COVID-19 susceptibility and severity
COVID-19 presents with a wide range of severity, from asymptomatic in some individuals to fatal in others. Based on a study of over one million 23andMe research participants, we report genetic and non-genetic associations with testing positive for COVID-19, respiratory symptoms, and hospitalization. Risk factors for hospitalization include advancing age, male sex, elevated body mass index, lower socio-economic status, non-European ancestry, and pre-existing cardio-metabolic and respiratory conditions. Using trans-ethnic genome-wide association studies, we identify a strong association between blood type and COVID-19 diagnosis, as well as a gene-rich locus on chr3p21.31 that is more strongly associated with outcome severity. While non-European ancestry was found to be a significant risk factor for hospitalization after adjusting for socio-demographics and pre-existing health conditions, we did not find evidence that these two primary genetic associations explain differences between populations in terms of risk for severe COVID-19 outcomes.